Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
902.70
5.65 (0.63%) Natco Pharma submits copy of clarification
Date: 23-06-2016With reference to new flashed on CNBC TV 18 stating ‘NATCO Pharma gets USFDA nod for Glycopyrrolate’, Natco Pharma has submitted a copy of clarification.
The above information is a part of company’s filings submitted to BSE.